Poly Medicure Limited (NSE:POLYMED)
1,846.90
-75.80 (-3.94%)
Aug 13, 2025, 2:30 PM IST
Poly Medicure Revenue
Poly Medicure had revenue of 4.03B INR in the quarter ending June 30, 2025, with 4.79% growth. This brings the company's revenue in the last twelve months to 16.88B, up 17.26% year-over-year. In the fiscal year ending March 31, 2025, Poly Medicure had annual revenue of 16.70B with 21.37% growth.
Revenue (ttm)
16.88B
Revenue Growth
+17.26%
P/S Ratio
11.52
Revenue / Employee
2.68M
Employees
6,300
Market Cap
194.53B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 16.70B | 2.94B | 21.37% |
Mar 31, 2024 | 13.76B | 2.61B | 23.36% |
Mar 31, 2023 | 11.15B | 1.92B | 20.82% |
Mar 31, 2022 | 9.23B | 1.37B | 17.37% |
Mar 31, 2021 | 7.86B | 992.31M | 14.44% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 537.77B |
Divi's Laboratories | 96.52B |
Cipla | 274.80B |
Apollo Hospitals Enterprise | 217.94B |
Mankind Pharma | 129.10B |
Zydus Lifesciences | 236.99B |
Fortis Healthcare | 80.94B |
Alkem Laboratories | 133.20B |
Poly Medicure News
- 2 days ago - Poly Medicure cuts FY26 export growth guidance to 5-10% from 15-18% earlier - Business Upturn
- 5 days ago - Poly Medicure Q1 Results: Revenue jumps 4.8% YoY to 403.21 crore, net profit up 25.8% YoY - Business Upturn
- 3 months ago - Poly Medicure shares surge 3% as Q4 revenue rises 16.6% YoY to Rs 441 crore - Business Upturn
- 4 months ago - Poly Medicure shares surge over 6% as Trump tariffs target Chinese medical imports; imposed 245% tariffs on syringes and needles - Business Upturn
- 6 months ago - Poly Medicure Ltd (BOM:531768) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amidst ... - GuruFocus
- 6 months ago - Q3 2025 Poly Medicure Ltd Earnings Call Transcript - GuruFocus
- 6 months ago - Poly Medicure Q3 FY25 Results: Revenue up 25% YoY to Rs 424 crore, net profit jump 31% YoY - Business Upturn
- 7 months ago - Poly Medicure announces Joint Venture for solar power project - Business Upturn